SCHEMBL21491219

SCHEMBL21491219

COC(=O)c1ccc(OC)c(C2COCCCN2C=O)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
MGLL Q99685 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 4/20 0.37
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDE4A P27815 3/20 0.37
PDE4B Q07343 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
MTOR P42345 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31472369 1.00 ALOX15 (0.39) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL31472393 1.00 ALOX15 (0.39) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL29456402 1.00 ALOX15 (0.39) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL21491314 0.90 CA12 (0.41) ALDH1A1MAPTKMT2AMEN1PDE4A
SCHEMBL25482907 0.88 HSP90AA1 (0.45) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL21491203 0.76 CRHBP (0.37) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL31472382 0.76 CRHBP (0.37) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL31472363 0.76 CRHBP (0.37) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL29456319 0.76 CRHBP (0.37) ALOX15ALDH1A1HPGDMGLLHSD17B10
SCHEMBL21491449 0.73 KMT2A (0.43) ALOX15ALDH1A1HPGDMGLLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188070-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2025-06-12 US disclosed
CN-112236428-B Antiproliferative compounds and uses thereof 默克专利股份有限公司 2025-04-01 CN disclosed
US-12195453-B2 Antiproliferation compounds and uses thereof MERCK PATENT GMBH (DE) 2025-01-14 US disclosed
EP-4043460-B1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MERCK PATENT GMBH (DE) 2024-06-05 EP disclosed
US-20230150993-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-05-18 US disclosed
US-20230150993-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-05-18 US disclosed
US-11440907-B1 Antiproliferation compounds and uses thereof MERCK PATENT GMBH (DE) 2022-09-13 US disclosed
EP-4043460-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF Merck Patent GmbH (DE) 2022-08-17 EP disclosed
EP-3784666-B1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MERCK PATENT GMBH (DE) 2022-03-16 EP disclosed
EP-3784666-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF Merck Patent GmbH (DE) 2021-03-03 EP disclosed
CN-112236428-A Antiproliferative compounds and uses thereof 默克专利股份有限公司 2021-01-15 CN disclosed
US-10815225-B2 Antiproliferation compounds and uses thereof MERCK PATENT GMBH (DE) 2020-10-27 US disclosed
US-10815225-B2 Antiproliferation compounds and uses thereof MERCK PATENT GMBH (DE) 2020-10-27 US disclosed
US-20190322658-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MERCK PATENT GMBH (DE) 2019-10-24 US disclosed
US-20190322658-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MERCK PATENT GMBH (DE) 2019-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322658-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885
US-12195453-B2 Antiproliferation compounds and uses thereof MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885
US-11440907-B1 Antiproliferation compounds and uses thereof MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885
US-20230150993-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885
US-10815225-B2 Antiproliferation compounds and uses thereof MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885
US-20250188070-A1 ANTIPROLIFERATION COMPOUNDS AND USES THEREOF MKI67, MCL1, CCNI ALOX15 952/4885ALDH1A1 263/4885HPGD 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.